| Christie Berkseth-rojas Llc | |
|
3455 4th Ave S Minneapolis MN 55408-4527 | |
| (612) 315-6955 | |
| Not Available |
| Full Name | Christie Berkseth-rojas Llc |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 3455 4th Ave S, Minneapolis, Minnesota |
| Authorized Official Name and Position | Christie Jo Berkseth-rojas (OWNER) |
| Authorized Official Contact | 6123156955 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Christie Berkseth-rojas Llc 3533 4th Ave S Minneapolis MN 55408-4528 Ph: (612) 730-5658 | Christie Berkseth-rojas Llc 3455 4th Ave S Minneapolis MN 55408-4527 Ph: (612) 315-6955 |
| NPI Number | 1033677208 |
|---|---|
| Provider Enumeration Date | 03/06/2019 |
| Last Update Date | 03/06/2019 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033677208 | NPI | - | NPPES |
| 1962795856 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
News Archive
UCLA scientists have devised a novel way to repair one of the genetic mutations that causes ataxia-telangiectasia, (A-T), a life-shortening disorder that devastates the neurological and immune systems of one in 40,000 young children.
Mast Therapeutics, Inc., a biopharmaceutical company developing novel, clinical-stage therapies for sickle cell disease and heart failure today announced that it has completed patient enrollment in its Phase 3 clinical study of vepoloxamer for the treatment of patients with sickle cell disease experiencing vaso-occlusive crisis, known as the EPIC study.
Myriad Genetics, announced today that an article entitled "Prevalence of BRCA1 and BRCA2 Mutations In Women With Carcinoma In Situ of the Breast Referred for Genetic Testing" will appear in the December 2010 issue of the journal Cancer Prevention Research.
Pathwork Diagnostics Inc., a molecular diagnostics company focused on oncology, today announced that it has entered into a research collaboration with Novartis. The parties intend to discover clinically meaningful biomarker signatures that can serve as the basis for diagnostics across a range of cancer types. Under the terms of the agreement, both parties have rights to develop and commercialize the diagnostic products. Financial terms were not disclosed.
The Board issued a Notice of Hearing on March 16, 2009, pertaining to allegations of Board Staff that Neulasta had been, and was being, sold by Amgen Canada Inc. at prices exceeding those indicated by the Board's Excessive Price Guidelines. On October 13, 2009, the Hearing Panel received a Joint Submission by Amgen and Board Staff along with a Voluntary Compliance Undertaking ("VCU") which proposed to resolve the issues raised in the Neulasta proceedings.
› Verified 4 days ago
Nicollet Dental Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 6101 Nicollet Ave. So., Minneapolis, MN 55419 Phone: 612-866-8550 Fax: 612-866-9453 | |
Craig J Brandenburg Dds Ltd Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5201 Bloomington Ave, Minneapolis, MN 55417 Phone: 612-721-6233 Fax: 612-721-5723 | |
Walker Dental Clinic Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 3737 Bryant Ave S, Minneapolis, MN 55409 Phone: 612-827-5931 Fax: 612-827-8458 | |
Park Dental Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2600 39th Ave Ne, 225, Minneapolis, MN 55421 Phone: 763-781-7475 Fax: 763-781-0828 | |
West River Dental Care Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 4103 E Lake St, Minneapolis, MN 55406 Phone: 612-721-2424 Fax: 612-721-3054 | |
Minneapolis Dental Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 150 S 5th St Ste 1475, Minneapolis, MN 55402 Phone: 612-332-1255 Fax: 612-388-3721 |